Translate page

  • Presentations from the EHA2022 Congress

  • EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)

  • EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)

  • COLT Meeting 2019: CML related topics

  • COLT Meeting 2019: The CML frontier

    Deborah White                                                                




    Biomarkers and response monitoring beyond PCR?
    Deborah White - SAHMRI, University of Adelaide

    • Predictive biomarkers
    • Cytokines, growth factors and chemokines: TGF and IL6
    • KIR2DS1 genotype and inferior cytogenetic response: SPIRIT1
    • CIP2A and response
    • Imatinib drug levels and compliance